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During the last two decades numerous genetic approaches affecting cell function
in vivo have been developed. Current state-of-the-art technology permits the selective
switching of gene function in distinct cell populations within the complex organization
of a given tissue parenchyma. The tamoxifen-inducible Cre/loxP gene recombination
and the doxycycline-dependent modulation of gene expression are probably the most
popular genetic paradigms. Here, we will review applications of these two strategies
while focusing on the interactions of astrocytes and neurons in the central nervous
system (CNS) and their impact for the whole organism. Abolishing glial sensing of
neuronal activity by selective deletion of glial transmitter receptors demonstrated the
impact of astrocytes for higher cognitive functions such as learning and memory, or the
more basic body control of muscle coordination. Interestingly, also interfering with glial
output, i.e., the release of gliotransmitters can drastically change animal’s physiology
like sleeping behavior. Furthermore, such genetic approaches have also been used to
restore astrocyte function. In these studies two alternatives were employed to achieve
proper genetic targeting of astrocytes: transgenes using the promoter of the human glial
fibrillary acidic protein (GFAP) or homologous recombination into the glutamate-aspartate
transporter (GLAST) locus. We will highlight their specific properties that could be relevant
for their use.
Keywords: genetic targeting of astrocytes, tamoxifen, CreERT2/loxP, Bergmann glia, human GFAP promoter,
GLAST glutamate aspartate transporter
Introduction
Astrocytes represent an abundant, but also heterogeneous group of glial cells in all regions of the
brain (Figures 1A–F). Their numerous interactions with capillaries and neurons are important
signaling pathways for physiological brain function. Astrocytes actively control signal processing
and transmission at the tripartite synapse (Perea et al., 2009). Originally, astrocytes were regarded
as silent non-excitable cells, since they do not communicate via electrical signals. But now, it has
become very clear that astroglial signaling is encoded in complex spatial and temporal patterns of
Ca2+ changes within subcellular compartments as well as throughout cellular networks coupled
by gap junctions. Intracellular Ca2+ rises indicate how they sense activity of their surroundings
(Zorec et al., 2012; Araque et al., 2014; Verkhratsky and Parpura, 2014). Intracellular changes of
another cation, Na+, have been recognized as an additional or alternative indicator of astrocyte
activation (Kirischuk et al., 2012; Verkhratsky et al., 2013; Rose and Chatton, 2015). Even over
longer distances astrocytes can convey various signals, e.g., inositol-1,4,5-trisphosphate (IP3) or
cyclic nucleotides that pass through gap junctions and functionally couple the astroglial syncytium
(Giaume and Liu, 2012; Theis and Giaume, 2012). Within these networks information spreads with
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FIGURE 1 | Astrocyte heterogeneity and gene targeting
strategies to influence astrocyte behavior. Throughout
development and in different brain regions, the heterogeneity of
astrocytes becomes rather obvious when looking at the different
morphologies. It is more the cell volume with cytosol and cell
membrane that helps to visualize astrocyte function rather than the
cytoskeletal structure (A–F). Only few genetic strategies have been
used to modify astrocyte function in vivo (G–J). (A) glial fibrillary
acidic protein (GFAP)-stained acutely isolated astrocyte. (B) Cortical
astrocytes expressing tdTomato in close contact to a blood vessel
with their end feet, (C) Hippocampal astrocytes (CA1) expressing
(Continued)
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FIGURE 1 | Continued
GFAP. (D) Single Bergmann glia (BG) cell with CreERT2/loxP controlled
reporter expression (EGFP). (E) Cortical astrocyte expressing EGFP and
surrounding a blood vessel. Scale bars: A,D,E = 10 µm, B = 20 µm,
C = 50 µm. (F) Electron micrograph depicting the intimate enwrapping of pre-
and postsynaptic terminals by astroglial processes (BG: Bergmann glial
processes, scale bar: 1 µm). (G) Knock-in of CreERT2 into the GLAST locus
leads to tamoxifen-sensitive recombination in all astrocytes with endogenous
GLAST promoter activity (Mori et al., 2006). The DNA recombinase variant
CreERT2 is trapped in the cytosol by heat shock proteins (HSP), after
tamoxifen application the protein is released and translocated into the
nucleus. (H,I) Transgenic GFAP-CreERT2 mice generated by non-homologous
recombination can also be used to target astrocytes (Hirrlinger et al., 2006).
The Cre/loxP system can either be used to selective excise gene alleles of
interest (G,H; knockout) or to express genes of interest (e.g., reporter proteins
such as GFP or genetically encoded Ca2+ indicators), but also to restore gene
function (I) (Lioy et al., 2011). (J) Alternatively, the binary tTA/tetO system
composed of (1) promoter-controlled expression of a tetracyclin transactivator
protein; and (2) tetracycline/doxycycline-responsive elements driving the
expression of proteins-of-interest (Pascual et al., 2005). This system allows for
a certain degree of reversible gene regulation.
tens of µm/s speed, still several orders of magnitude slower
than the propagation of neuronal action potentials (Haydon
and Nedergaard, 2015). The interactions of astrocytes with
neurons are largely based on astroglial receptors that sense
neuronal communication or on the release of gliotransmitters
acting back on synaptic transmission. The general importance
of astrocytes for brain function is uncovered by the devastating
point mutations in single genes encoding transcription factors
since these factors can control extended sets of gene programs.
Genetically modified mice addressing astrocyte function have
been instrumental in uncovering their role in the living animal.
In general, transgenic mouse models that interfere with cell
function can be categorized in three classes: (1) Modulation
of information input by direct knockout of receptors or
signaling molecules, thereby preventing the information to
enter the cell; it becomes insensitive; (2) Cell perturbation of
intracellular gene programs or metabolic pathways, e.g., by
knockout of transcription factors or enzymes involved in signal
processing and resulting changes of the cellular infrastructure;
and (3) Inhibition of signal release to the adjacent cellular
neighborhood; the astrocyte becomes inactive or silent.
Conditional gene deletions started with the use of cell-
specific promoters driving the Cre DNA recombinase (Cre/loxP
system) to abolish gene function in selected cell types. However,
several of such regulatory elements were active in precursor
cells during embryonic development, thereby affecting complete
lineage trees. To achieve temporal control of cell-specific DNA
recombination, tamoxifen-sensitive, i.e., inducible variants of
the Cre DNA recombinase were developed (CreER, CreERT,
CreERT2). Here, the DNA recombinase Cre is fused to a
mutated ligand-binding domain of the human estrogen receptor
(ER), which does not bind endogenous estradiol, but is highly
sensitive to nanomolar concentrations of 4-hydroxytamoxifen,
a metabolite of tamoxifen that can be applied intraperitoneally,
but also by gavage (Feil et al., 1997; Metzger and Chambon,
2001; Weber et al., 2001; Hirrlinger et al., 2006; Mori and Zhang,
2006).
Here, we will review current genetic strategies to reveal
the impact of astrocyte function in the brain by focusing
on frequently used paradigmatic examples (Figures 1G–J):
tamoxifen-sensitive cell-specific gene deletion and restoration as
well as doxycycline-induced expression of functionally impaired,
dominant-negative signaling molecules. The tamoxifen-sensitive
CreERT2/loxP system provides temporal control of gene deletion
(Hirrlinger et al., 2006; Mori et al., 2006), in contrast to
conventional mouse models with Cre/loxP (Malatesta et al.,
2003). The doxycycline/tTA model can be used for transient
effector protein expression (Bujard, 1999; Mansuy and Bujard,
2000; Pascual et al., 2005).
In the first part we will shortly describe the mouse models
and their associated astrocyte function. In the second part,
we will compare the targeting of astrocytes using regulatory
elements of the human glial fibrillary acidic protein (GFAP)
promoter with expression from the GLAST gene locus directly,
and deduce respective technical considerations and scientific
limitations.
The Role of Astrocytes in Hippocampal
Learning
The functional role in working memory and its molecular
signaling of the hippocampal CA3-CA1 synapse have been
well characterized (Neves et al., 2008; Bannerman et al.,
2014). A diversity of endogenous compounds is capable
of modulating its transmission and thereby affecting our
memory. Interestingly, one of the most abundant G-protein
coupled receptors of the brain, the cannabinoid type-1 receptor
(CB1R), has been detected on all hippocampal cell types
(Marsicano and Lutz, 1999). Based on work performed on
brain slices, endocannabinoids or the synthetic drug ∆9-
tetrahydrocannabinol (THC), better known as marijuana, are
thought to inhibit presynaptic transmitter release via CB1R
activation, thereby depressing excitatory neurotransmission,
and finally, impairing spatial working memory (Misner and
Sullivan, 1999; Carlson et al., 2002; Takahashi and Castillo,
2006; Bajo et al., 2009; Schoeler and Bhattacharyya, 2013).
Also in vivo THC was found to cause long-term depression
(LTD; Hampson and Deadwyler, 2000; Mato et al., 2004;
Madroñal et al., 2012). However, when the impact of CB1R
was tested more selectively using genetically modified mice
with cell-specific receptor deficiency, unexpectedly, it was the
ablation of the astroglial (Figure 1H; GFAP-CreERT2 × floxed
CB1R), but not the neuronal CB1R that completely abolished
THC-dependent depression (Figure 2A; Han et al., 2012). For
their analysis, the authors used mice with at least 4 weeks of
time to allow efficient receptor protein degradation. Although
30% of CB1R protein could still be detected using immune-
EM, the receptor function in modulating synaptic efficacy,
i.e., LTD, was completely gone. In parallel, the mutant mice
remained unaffected after THC injection when behaviorally
tested in a variant of the Morris water maze. Thereby, this
study demonstrates the pivotal role of astrocytes in modulating
synaptic transmission and respective circuit-associated learning
behavior.
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FIGURE 2 | Genetic mouse models reveal a diversity of astrocyte
functions affecting mouse behavior. (A) Astroglial cannabinoid
receptors are involved in spatial memory formation (Han et al., 2012).
(B) The ionotropic glutamate receptors on BG contribute to fine motor
coordination (Saab et al., 2012). (C) Although the lack of the widely
expressed transcriptional repressor MECP2 results in synapse loss,
severe mental retardation and premature death, the astrocyte-specific
re-expression restores several vital functions like motor activity (Lioy et al.,
2011). (D) Impairment of astroglial ATP release perturbs sleep behavior
and induces memory loss (Pascual et al., 2005; Halassa et al., 2009).
Cerebellar Bergmann Glia Fine Tune Neural
Circuits of Motor Coordination
The neural circuits of the cerebellum control the timing of
motor performance by integrating sensory and motor input
of climbing and mossy fibers (De Zeeuw et al., 2011; Heck
et al., 2013). While climbing fibers (CF) multiply innervate the
principal neurons, i.e., the Purkinje cells (PC); the information
from mossy fibers is relayed via granule cells and their parallel
fibers (PF). Both synapses, CF-PC and PF-PC, are characterized
by their almost complete coverage by membrane appendages
emanating from the main radially oriented processes of the
Bergmann glia (BG; Figures 1D,F; Grosche et al., 2002; Lippman
et al., 2008; Lippman Bell et al., 2010). The perisynaptic glial
membranes are equipped with a tremendously high density of
glutamate transporter to strictly control the extracellular levels
of the excitatory transmitter and preventing synaptic spillover
(Tong and Jahr, 1994; Marcaggi et al., 2003; Takayasu et al.,
2006, 2009). Surprisingly, BG processes were found to express
another glutamate sensing mechanism, ionotropic glutamate
receptors very similar to neurons (Müller et al., 1992). The
heteromeric ion channel complexes are formed by an assembly
of the AMPA-type receptor subunits GluA1 and GluA4 (Geiger
et al., 1995). However, in contrast to several neuronal AMPA
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receptors, the BG receptor channels are Ca2+ permeable since
they lack expression of the GluA2 subunit. While the importance
of efficient glutamate uptake at excitatory synapses appears quite
obvious, the expression of fast desensitizing AMPA receptors
on BG remained enigmatic till very recently. To completely
abolish AMPA receptor function in BG, another astrocyte-
specific mouse, the GLAST-CreERT2 knockin (gene: slc1a3;
Mori et al., 2006; Figures 1G, 2B) was used to delete GluA1
and GluA4 simultaneously (Saab et al., 2012). In young mice
(2 to 4 weeks old) GluA1/4 deletion resulted in retraction of
glial appendages from PC synapses, an increased amplitude and
duration of evoked postsynaptic PC currents, and a delayed
formation of glutamatergic synapses. In adult (older than 2
months) mice, GluA1/4 inactivation also caused retraction of
glial processes. In addition, the study provided a detailed time
course for tamoxifen-evoked gene excision as well as mRNA
and protein degradation. While the recombination event was
almost completed after 2 days, the mRNA persisted for a week
and the protein for even 3 weeks. The mutant mice showed
normal behavior when observed in their cages. However, when
the mice were challenged by a complex motor task running along
a horizontal ladder with suddenly appearing obstacles, their
fine motor coordination was significantly impaired (Figure 2B).
Thus, AMPA receptors of BG are essential to optimize synaptic
integration and cerebellar output function throughout life.
AMPA receptor signaling of BG contributes to the structural
and functional integrity of the cerebellar network and plays
an important role in the ‘‘fine-tuning’’ of neuronal processing,
which is crucial for a fast and precise control of complex motor
behaviors (Saab et al., 2012).
Astrocyte-Specific Intracellular Gene
Regulation in Signal Conversion
The above examples demonstrate how important astrocytes
are in extracellular sensing of neuronal activity. Important
intracellular functions such as detoxification or gene regulation
can already be significantly affected by single point mutations in
genes encoding enzymes or transcription factors, as observed in
a variety of neurological disorders. A particularly well studied
example is the methyl-CpG binding protein 2 (MECP2) that
acts as a transcriptional repressor and affects the activity of
broad range of downstream genes (Chahrour and Zoghbi, 2007).
Mutations of the X-linked MECP2 gene cause Rett syndrome,
a neurodevelopmental disorder. At the end of infancy patients
suffer from progressing synaptic malfunctions associated with
severe mental retardation (Chahrour and Zoghbi, 2007). Since
loss-of-function mutations in mice phenocopy the human
disease, genetic rescue experiments were performed to re-
introduce the fully functional wild type gene. And indeed, global
gene rescue restored brain development and function (Guy
et al., 2007). Interestingly, neuron-specific restoration prevented
several, but not all Rett-associated symptoms (Alvarez-Saavedra
et al., 2007). Since MECP2 can be detected in astrocytes as
well, it was selectively re-introduced in astrocytes using GFAP-
CreERT2 mice crossbred to genetically modified mice with
the MECP2 open reading frame encoded by the endogenous
gene, but separated from the promoter region by a Cre-
excisable STOP fragment (Figures 1I, 2C; Lioy et al., 2011).
Tamoxifen treatment of mutant mice prolonged the lifespan to
7.5 months when compared to oil-treated animals that already
died at 3 months of age. Phenotype differences became evident
6 weeks after tamoxifen-induced MECP2 re-expression. Even
highly symptomatic MeCP2stop/y mice could be rescued. While
MECP2-deficient mice were hyperactive and quite anxious,
behavioral testing in the open field and water maze revealed an
improvement to 50% of control levels (Figure 2C). Similar to
Rett patients, 12-week-old MeCP2stop/y mice displayed strong
breathing problems, but 2 months after tamoxifen-induced
rescue the respiration pattern recovered to a normal range.
Interestingly, the astrocyte-specific deletion of MeCP2, induced
at an age of 3 weeks, caused several pathological symptoms such
as smaller body size, clasped hindlimb posture and irregular
breathing 10 weeks later as observed in the global knockout mice
(Han et al., 2012). Lifespan, locomotion and anxiety behavior,
however, remained normal. Thereby, these data suggest distinct
mechanisms of neuron–astrocyte interactions in different neural
circuits of forebrain (anxiety, motor behavior) and hindbrain
(control of respiration).
Astrocytes Modulate Synaptic
Transmission
One genetic mouse model in glia research has received particular
attention and is currently heavily debated, the doxycycline-
switchable dnSNARE mouse (Pascual et al., 2005; Sloan and
Barres, 2014; Haydon and Nedergaard, 2015; Figures 1J, 2D). In
this paragraph we will provide only a description of the positive
findings that have been made. In the last part of this section we
will shortly address the current discussion.
A very clear and evident way how astrocytes affect neural
circuits became obvious when the regulated secretion of
gliotransmitters such as glutamate, ATP or D-serine was
investigated (Pascual et al., 2005). For this purpose a different
switchable genetic mouse model was developed: the tetracycline-
dependent expression of dominant-negative (dn) soluble
N-ethylmaleimide-sensitive factor attached receptor (SNARE)-
proteins that disrupt the vesicular release of gliotransmitters.
Transgenic mice with human GFAP promoter-driven expression
of the tetoff tetracycline transactivator (tTA;Mansuy and Bujard,
2000) were crossbred to mice with a tTA responsive element (tet
operator, tetO) regulating expression of dnSNARE and reporter
proteins (Figure 1J). In the presence of dietary doxycycline, a
tetracycline derivative with improved permeability for the blood-
brain barrier, the expression of dnSNAREs and reporter proteins
is suppressed. Two weeks after stopping doxycycline, astrocytes
efficiently express dnSNAREs and block their vesicular release
of gliotransmitters (Figure 2D), in particular of ATP that is
further degraded to adenosine. And indeed, electrophysiological
analysis of hippocampal slices reveal enhanced field potentials
after Schaffer collateral stimulation in dnSNARE mice (Pascual
et al., 2005). Extracellular adenosine, generated from released
ATP, acts on presynaptic A1 receptors and suppresses excitatory
synaptic transmission. Blocking the constitutive ATP/adenosine
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release from astrocytes enhances the excitatory drive that can
be blocked by exogenous application of ATP (Pascual et al.,
2005). By releasing activity dependent neurotransmitters,
astrocytes regulate the strength of basal synaptic transmission
at the circuit level. At system and behavioral level, impaired
astroglial ATP release reduces the slow wave activity in the
electroencephalogram (EEG), perturbs sleep homeostasis and
sleep loss-associated memory deficits (Figure 2D; Halassa et al.,
2009).
In a recent study severe concerns about the use of the
transgenic dnSNARE mice have been raised (Fujita et al., 2014).
The authors criticize an insufficient early characterization of
the mice and present own data that suggest a predominant
neuron-mediated impairment of ATP signaling rather than an
astroglial one. Without joining this discussion, it is evident
that far-reaching conclusions from genetically engineered animal
models should be based on independent experimental systems.
But this should be immanent to all types of science. Continuous
generation of novel mouse models and their free sharing within
the scientific community will warrant the progress in our
understanding of brain function.
Technical Considerations When Using
Genetically Modified Mice to Target
Astrocyte Functions
Astrocytes are not only widely distributed throughout all regions
of the brain, age and brain-region specific expression of genes
and their distinct functions have been identified (Malatesta et al.,
2003; Regan et al., 2007; Halassa et al., 2009; Robel et al.,
FIGURE 3 | Comparison of tamoxifen-induced DNA recombination in
GLAST-CreERT2 and GFAP-CreERT2 mice. Comparison of DNA
recombination in transgenic GFAP-CreERT2 and GLAST-CreERT2 knockin
mice. (A,B) Sagittal overview of tdTomato reporter expression (Madisen
et al., 2010) in the brain of GLAST-CreERT2 and GFAP-CreERT2 mice.
(C–H) Magnified views of selected brain regions (ctx, cortex; hc,
hippocampus; th, thalamus; hy, hypothalamus; col, superior colliculus; bs,
brainstem). The upper panel shows reporter activation in GFAP-CreERT2
mice, the lower panel in GLAST-CreERT2. (I–K) In the cerebellum,
tdTomato reporter activation of BG and other astrocytes is comparable in
GFAP-CreERT2 and GLAST-CreERT2 mice (I) however, gene deletion (here
GluA1) is more efficient (K) in BG of GLAST-CreERT2 mice (lower panel)
than in GFAP-CreERT2 mice (upper panel) when compared to control
mice (J).
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 August 2015 | Volume 9 | Article 310
Jahn et al. Genetic control of astrocyte function
2009, 2011; Gourine et al., 2010; Lioy et al., 2011; Han et al.,
2012; Saab et al., 2012). Therefore, the selection of regulatory
elements of THE astrocyte-specific gene is almost impossible.
Historically, the promoter of the human GFAP gene has become
a widely distributed and valuable tool. Its small size of 2.2 kb
offered excellent cloning properties and facilitated its use for
transgenic expression of numerous proteins of current interest
such as EGFP or CreERT2 (Nolte et al., 2001; Hirrlinger et al.,
2006). In parallel, as an alternative genetic tool, GLAST-CreERT2
mice were generated by targeting the tamoxifen-sensitive Cre
DNA recombinase CreERT2 to exon 2 of the GLAST locus
using homologous recombination (Mori et al., 2006). Direct
comparison of both mouse lines revealed variable differences
in brain region-dependent recombination although they largely
overlap (Figure 3). While recombination in GLAST-CreERT2
mice dominates forebrain regions, the GFAP-CreERT2 mouse
displays higher recombination efficiencies in the hindbrain.
Particular differences become evident when not only reporter
proteins are activated, but when gene knockout experiments
require the recombination of homozygous alleles as observed for
the deletion of the ionotropic glutamate receptor subunit GluA1
in cerebellar BG (Figures 3J,K). In GLAST-CreERT2 mice the
immunohistochemical signal indicating GluA1 was completely
abolished to background levels 4 weeks after induction of
recombination, while in GFAP-CreERT2 mice GluA1 expression
still remained in numerous BG cells.
It is important to note that only heterozygous GLAST-
CreERT2mice can be used. Homozygous GLAST-CreERT2mice
will be knockouts of the GLAST-dependent glutamate uptake.
Interestingly, we found that, although heterozygous mice express
only 50% of GLAST mRNA and protein in comparison to wild
type mice, the functional glutamate uptake current appears to be
unaffected (Saab et al., 2012).
Although the GFAP-CreERT2 and GLAST-CreERT2 mice
have been successfully used in a series of studies including
behavioral experiments, both suffer from recombination
in radial glia of the neurogenic niches (Hirrlinger et al.,
2006; Mori et al., 2006; DeCarolis et al., 2013). The DNA
recombination induced in the respective neuronal progeny
might contribute to a phenotype in conditional knockout
experiments and careful control experiments should be
employed. Alternative lines such as Connexin43-CreERT
mice (Eckardt et al., 2004) without neuronal recombination in
stem cells have not yet been used for behavioral experiments.
Similarly, behavioral experiments with astrocyte-specific
AldhL1- or FGFR3-CreERT2 mice might also be difficult since
recombination can also be induced in neural stem cells or
interneurons (Young et al., 2010; Yang et al., 2011; Foo and
Dougherty, 2013).
Tamoxifen-induced gene recombination is a very valuable
tool to temporally control gene excision. But, one has to
keep in mind that gene excision does not mean simultaneous
disappearance of the respective protein. The half-lifes of mRNA
and protein have to be considered. In case of the glutamate
receptors GluA1 and GluA4, their efficient functional removal
required about 2 weeks (Saab et al., 2012). In addition, the age
of the mice (i.e., the level of gene activity) influenced the protein
turnover as well.
In the future, genetic targeting of astrocytes has to become
more sophisticated. It is now clear that astrocytes of different
brain regions can fulfill different functions. Therefore, we have to
identify novel regulatory elements that can be used to address the
astroglial heterogeneity, either by targeting astrocytes of distinct
brain regions locally or functionally, e.g., after injury or during
a learning paradigm. The numerous transporter genes could
be a rich source. The thyroid hormone transporter OATP1C1
is such an example. This transporter is expressed by cortical
or hippocampal astrocytes, but not in the brainstem (Schnell
et al., 2013). In addition, the coincident use of two different
gene loci and employing the split-Cre system could provide
another strategy to target subclasses of astrocytes (Hirrlinger
et al., 2009a,b).
Current efforts in obtaining cell type, age and brain region-
dependent gene expression profiles will facilitate the quest for
suitable regulatory elements to target astrocytes. Future mouse
models will then help to further highlight selective astrocyte
function of distinct central nervous system (CNS) regions or
learning paradigms.
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